virus
infecti
biolog
agent
lack
abil
replic
independ
specif
lack
translat
metabol
machineri
therefor
oblig
intracellular
parasit
viral
particl
consist
either
rna
dna
genom
surround
protein
capsid
protect
genet
materi
certain
virus
addit
envelop
lipid
bilay
deriv
host
membran
order
propag
virus
must
use
host
cell
system
assembl
new
rna
dna
protein
lipid
envelop
though
detail
viral
life
cycl
vari
viru
viru
five
gener
stage
cell
entri
translat
viral
protein
replic
genom
assembl
viral
particl
egress
cell
fig
activitybas
profil
use
broadli
characteris
interact
approach
use
discoveri
techniqu
accord
highlight
herein
molecular
process
involv
viru
propag
requir
divers
energi
molecular
build
block
essenti
resourc
need
divert
host
cell
system
pathway
process
need
viru
import
note
metabol
energi
consum
synthesi
new
viral
particl
also
remodel
cellular
environ
meet
demand
viru
virus
requir
specif
often
tightli
regul
condit
propag
effici
good
exampl
lie
replic
positivestrand
rna
virus
occur
within
specialis
region
call
replic
organel
ro
neufeldt
et
al
organel
creat
optim
environ
replic
allow
concentr
requir
host
viral
factor
shield
viral
rna
innat
immun
respons
neufeldt
et
al
morpholog
organel
differ
viru
viru
spheric
tubular
origin
er
golgi
bodi
endosom
lysosom
compos
singl
doubl
multimembran
vesicl
novoa
et
al
neufeldt
et
al
membran
furthermor
possess
specif
lipid
profil
uniqu
viru
rubella
viru
ro
requir
elev
satur
fatti
acid
level
west
nile
viru
hepat
c
viru
enterovirus
requir
high
cholesterol
harak
lohmann
paul
bartenschlag
hepat
c
ro
also
requir
elev
level
sphingolipid
phosphoryl
phosphoinosid
pip
hsu
et
al
harak
lohmann
paul
bartenschlag
larg
amount
metabol
energi
requir
chang
lipid
profil
cell
manner
necessit
signific
perturb
normal
lipid
homeostasi
divers
metabol
energi
remodel
host
cell
architectur
initi
viral
enzym
howev
direct
modif
cellular
architectur
viral
enzym
alway
feasibl
due
small
rang
function
encod
virus
chang
host
cell
function
chang
abund
activ
key
enzym
induc
viru
homeostat
respons
virusinduc
chang
well
immunolog
respons
infect
viral
genom
extrem
small
hepat
b
viru
exampl
genom
kb
long
liang
result
virus
utilis
machineri
cell
infect
replic
genom
assembl
new
viral
particl
releas
subsequ
reinfect
new
host
cell
function
chang
induc
either
directli
indirectli
often
result
chang
enzym
catalyt
activ
viral
hostderiv
enzym
interrog
chang
enzymat
activ
viral
infect
therefor
essenti
form
complet
understand
mechan
viru
infect
activitybas
protein
profil
abpp
techniqu
barglow
cravatt
cravatt
et
al
ideal
suit
answer
question
perturb
enzym
function
interact
techniqu
use
small
molecul
probe
coval
label
activ
enzym
inact
enzym
remain
unmodifi
includ
report
tag
probe
possibl
quantit
report
differ
level
activ
enzym
within
complex
proteom
sampl
chapter
describ
contribut
made
abpp
understand
interact
abpp
suppli
divers
toolbox
activitybas
probe
appli
studi
viral
host
enzym
identifi
host
enzym
dysregul
differ
stage
viral
infect
determin
viru
effect
chang
character
viral
enzym
function
structur
catalyt
inhibitori
mechan
fig
virus
entri
process
consist
recognit
target
cell
attach
cell
membran
internalis
viru
cell
usual
endocyt
pathway
releas
viral
genet
materi
cytosol
cell
case
envelop
virus
requir
fusion
viral
envelop
endosom
membran
form
pore
genet
materi
pass
mechan
format
pore
vari
virus
mani
requir
significantli
differ
host
cell
condit
factor
induc
fusion
major
focu
effort
design
novel
pharmaceut
develop
cell
entri
inhibitor
target
cell
entri
prevent
spread
infect
well
irrevers
damag
tissu
caus
infect
furthermor
host
factor
viral
factor
usual
target
imped
emerg
drugresist
strain
antivir
pharmaceut
target
cell
entri
develop
hepat
b
viru
human
immunodefici
viru
hiv
herpesvirus
de
clercq
li
sun
et
al
de
castro
camarasa
entri
inhibitor
virus
hcv
current
develop
xiao
et
al
qian
et
al
virus
sar
coronaviru
shown
requir
activ
lysosom
cathepsin
cathepsin
l
order
enter
cytosol
bosch
et
al
cathepsin
l
cleav
sarscov
spike
protein
found
viral
envelop
therebi
activ
allow
membran
fusion
proceed
bosch
et
al
furthermor
demonstr
play
accessori
role
ebola
infect
cleav
protein
conjunct
cathepsin
b
trigger
membran
fusion
chandran
et
al
epoxidebas
peptidemimet
probe
develop
label
cystein
proteas
class
includ
cathepsin
greenbaum
et
al
shah
et
al
appli
probe
studi
novel
sar
ebola
viru
entri
inhibitor
competit
abpp
shah
et
al
cell
treat
novel
inhibitor
demonstr
significantli
reduc
label
indic
abl
target
cathepsin
l
live
cell
suggest
inhibit
viral
entri
target
cathepsin
l
shah
et
al
studi
demonstr
abp
appli
develop
novel
pharmaceut
target
cell
entri
one
pronounc
hcvinduc
chang
cell
architectur
appear
larger
numer
lipid
droplet
near
site
viral
replic
neufeldt
et
al
result
increas
fatti
acid
synthesi
decreas
fatti
acid
oxid
secret
sy
et
al
fatti
acid
synthas
fasn
enzym
respons
de
novo
synthesi
fatti
acid
associ
hcv
replic
earli
howev
natur
interact
hcv
fasn
complet
characteris
su
et
al
probe
base
inhibitor
orlistat
orlistatalkyn
shown
strongli
select
label
activ
fasn
yang
et
al
probe
use
investig
hcv
alter
fasn
activ
compar
chang
protein
express
probe
label
nasheri
et
al
determin
fasn
activ
significantli
increas
hcv
replic
increas
protein
express
posttransl
activ
nasheri
et
al
imag
activ
fasn
use
orlistatalkyn
probe
demonstr
hcv
alter
localis
fasn
indic
posttransl
regul
fasn
occur
anoth
mechan
nasheri
et
al
increas
activ
fasn
hcv
replic
confirm
use
probe
contain
warhead
nasheri
et
al
hcvmediat
upregul
intracellular
lipid
shown
regul
via
numer
mechan
addit
increas
lipid
synthesi
decreas
lipolysi
lipid
secret
also
demonstr
play
signific
role
sy
et
al
singaravelu
et
al
use
novel
activitybas
probe
phenyl
sulfon
ester
warhead
ps
identifi
enzym
display
differenti
activ
hcv
replic
singaravelu
et
al
ps
probe
shown
label
enzym
involv
fatti
acid
electron
transfer
flavoprotein
subunit
alpha
etfa
comparison
label
hcvreplic
cell
show
decreas
etfa
activ
hcv
replic
suggest
target
etfa
may
mechan
hcv
reduc
lipid
oxid
increas
intracellular
lipid
level
singaravelu
et
al
recent
studi
nourbakhsh
et
al
use
fluoresc
label
fluorophosphon
probe
fig
show
desthiobiotinlabel
variant
profil
serin
hydrolas
activ
infect
vs
hepatoma
cell
identifi
one
enzym
arylacetamid
deacetylas
aadac
significantli
downregul
hcv
infect
nourbakhsh
et
al
subsequ
demonstr
aadac
induc
lipolysi
decreas
vldl
secret
lipid
therebi
decreas
level
intracellular
triglycerid
nourbakhsh
et
al
altogeth
studi
demonstr
hcv
decreas
activ
serin
hydrolas
aadac
order
increas
intracellular
lipid
level
via
inhibit
lipolysi
lipid
secret
phosphatidylinositid
pi
minor
compon
intracellular
membran
play
import
role
establish
organel
ident
propag
cell
signal
certain
speci
addit
shown
abl
induc
high
membran
curvatur
mcmahon
gallop
phosphoryl
speci
pi
shown
upregul
membran
web
hypothesis
play
role
establish
morpholog
membran
web
hsu
et
al
et
al
synthesis
pi
four
pikinas
pik
differenti
localis
within
cell
et
al
ident
kinas
contribut
hcvmediat
upregul
level
within
replic
complex
subject
signific
interest
delang
et
al
et
al
pik
pika
well
establish
hcv
host
factor
role
pik
pikb
infect
remain
ambigu
delang
et
al
order
investig
activ
hcv
infect
sherratt
et
al
synthesis
novel
activitybas
probe
pikbpyn
deriv
wellknown
revers
pik
activesit
inhibitor
fig
sherratt
et
al
warhead
probe
contain
group
enabl
select
interact
activ
pik
uvinduc
benzophenon
crosslink
form
coval
bond
probe
protein
target
use
probe
shown
activ
express
upregul
hcv
infect
sherratt
et
al
find
illustr
import
role
abpp
play
characteris
dysregul
host
factor
virus
increas
activ
correl
increas
protein
express
activ
hypothesis
regul
posttransl
activ
known
regul
stabl
interact
recruit
membran
stabilis
activ
phosphoryl
hausser
et
al
balla
investig
role
interact
posttransl
regul
activ
desroch
et
al
synthesis
new
pikbpyn
probe
contain
flexibl
linker
vari
length
target
moieti
crosslink
benzophenon
desroch
et
al
flexiblelink
pikbpyn
probe
shown
abl
label
protein
interact
activ
label
pikbpyn
demonstr
hcvinduc
decreas
interact
golgiresid
protein
desroch
et
al
previous
report
hcv
induc
chang
localis
golgi
toward
site
viral
replic
zhang
et
al
find
suggest
upregul
level
membran
web
hcv
replic
may
occur
partial
disrupt
interact
allow
relocalis
doublemembran
vesicl
hcv
replic
site
shown
contain
elev
level
cholesterol
neufeldt
et
al
activitybas
probe
appli
characteris
process
cholesterol
metabol
hijack
hcv
replic
fluorophosphonatebas
probe
use
profil
serin
hydrolas
activ
hcv
replic
order
identifi
enzym
differenti
regul
viru
blai
et
al
b
carboxylesteras
liverabund
serin
hydrolas
display
cholesteryl
ester
hydrolas
activ
identifi
target
activitybas
label
fluorophosphonatebas
peptidebas
probe
contain
either
serin
threonin
moieti
ross
et
al
blai
et
al
b
activ
shown
play
role
decreas
level
intracellular
cholesteryl
ester
well
secret
intracellular
triglycerid
vldl
pathway
zhao
et
al
ross
et
al
furthermor
demonstr
activ
alway
correl
express
suggest
regul
function
reli
posttransl
modif
interact
ross
et
al
activitybas
label
therefor
ideal
suit
interrog
function
fluorophosphon
peptidebas
probe
demonstr
significantli
increas
activ
hcv
replic
suggest
activ
part
host
cell
antivir
strategi
counteract
viral
induc
increas
cholesterol
triglycerid
blai
et
al
b
warhead
probe
describ
also
use
investig
cholesterol
metabol
enzym
probe
shown
label
hydroxymethylglutarylcoa
synthas
enzym
catalys
earli
step
cholesterol
synthesi
mazein
et
al
nasheri
et
al
label
probe
show
increas
activ
hcv
replic
suggest
differenti
activ
enzym
mechan
hcv
induc
format
favour
replic
environ
nasheri
et
al
find
provid
confirm
suggest
role
hcv
infect
kapadia
chisari
mani
chang
activ
lipid
metabol
enzym
result
alter
posttransl
mechan
regul
chang
activ
signal
pathway
control
posttransl
regul
therefor
great
interest
mani
signal
pathway
reli
kinas
activ
profil
kinas
activ
therefor
potenti
provid
inform
regul
multipl
cell
system
pathway
probe
wortmanninyn
base
irrevers
kinas
inhibitor
wortmannin
design
abl
broadli
profil
kinas
activ
desroch
et
al
comparison
label
wortmanninyn
cell
replic
hcv
cell
identifi
multipl
regulatori
kinas
whose
catalyt
activ
alter
hcv
kinas
mapk
pathway
particular
display
signific
decreas
desroch
et
al
studi
confirm
previou
report
hcvmediat
decreas
mapk
signal
demonstr
abp
use
profil
kinas
activ
section
describ
abp
target
lipid
metabol
enzym
use
profil
chang
regul
lipid
viral
infect
hijack
lipid
homeostasi
major
contributor
divers
metabol
energi
infect
howev
metabol
pathway
also
perturb
infect
glycolysi
particular
target
multipl
divers
virus
includ
hcv
influenza
viru
sever
herpesvirus
though
mechan
glycolysi
misregul
fulli
understood
goodwin
et
al
develop
novel
probe
target
glucos
metabol
enzym
repres
opportun
increas
understand
metabol
flux
viral
infect
fundament
aspect
innat
immun
respons
infect
lie
activ
apoptot
cell
death
pathway
upon
viral
invas
cell
order
restrict
spread
infect
throughout
host
barber
commerci
peptidebas
probe
flicatm
establish
chemicalbas
tool
studi
apoptosi
furman
et
al
probe
design
report
activ
caspac
enzym
essenti
progress
apoptosi
furman
et
al
use
probe
furman
et
al
determin
noroviru
infect
induc
apoptosi
demonstr
signific
increas
caspac
activ
mass
spectrometri
analysi
enzym
label
probe
reveal
equal
capabl
report
activ
cystein
proteas
cathepsin
b
shown
cathepsin
b
activ
noroviru
infect
act
upstream
activ
apoptot
pathway
furman
et
al
cathepsin
lysosom
aspart
peptidas
also
shown
induc
apoptosi
bene
et
al
use
peptidebas
probe
contain
phenylalanin
target
group
blai
et
al
demonstr
hcv
significantli
downregul
activ
cathepsin
suggest
hcv
decreas
cathepsin
activ
order
avoid
apoptosi
infect
cell
blai
et
al
activ
antiapoptot
gene
also
demonstr
infect
dengu
viru
close
rel
hcv
novel
atpbas
probe
contain
acyl
phosphat
warhead
use
profil
activ
kinas
dengu
infect
vetter
et
al
activ
dnadepend
protein
kinas
dnapk
antiapoptot
enzym
recognis
repair
dna
doublestrand
break
shown
significantli
upregul
dengu
infect
vetter
et
al
altogeth
abpp
shown
hcv
dengu
viru
act
counteract
activ
apoptot
pathway
proteasom
multisubunit
structur
respons
degrad
damag
excess
protein
within
cell
play
essenti
role
protein
qualiti
control
cell
signal
immun
respons
apoptosi
kammerl
meiner
specialis
form
proteasom
immunoproteasom
consist
mani
regulatori
subunit
addit
three
variant
catalyt
subunit
found
immunoproteasom
ferrington
gregerson
specialis
form
proteasom
play
role
direct
activ
adapt
immun
system
induc
infect
gener
peptid
hydrophob
cterminu
cellsurfac
display
mhc
class
molecul
cell
surveil
peptid
propag
immun
respons
upon
recognit
foreign
materi
ferrington
gregerson
exist
mix
proteasom
contain
constitut
express
immunoproteasom
subunit
also
demonstr
indic
categori
catalyt
subunit
could
implic
immun
respons
kammerl
meiner
catalyt
activ
proteasom
subunit
though
serin
hydrolas
contain
nucleophil
threonin
catalyt
residu
marqu
et
al
nasheri
et
al
shown
label
activitybas
probe
fluorophosphon
fig
shahiduzzaman
et
al
use
fluorophosphonatebas
probe
shahiduzzaman
et
al
shown
activ
sever
proteasom
subunit
increas
influenza
infect
possibl
due
increas
immunoproteasom
activ
shahiduzzaman
et
al
though
fluorophosph
abl
interrog
activ
proteasom
subunit
sever
subunit
detect
probe
abl
specif
quantit
assess
activ
possibl
catalyt
subunit
proteasom
develop
variou
group
past
decad
first
develop
peptidemimet
probe
conjug
bodipi
fluorophor
label
catalyt
activ
proteasom
subunit
verdo
et
al
specif
probe
later
develop
probe
specif
subunit
immunoproteasom
analogu
probe
specif
analogu
fig
li
et
al
keller
et
al
probe
appli
keller
et
al
investig
perturb
proteasom
system
viral
infect
proteasom
activ
shown
increas
murin
gammaherp
viru
infect
use
generalus
probe
use
assess
chang
catalyt
activ
proteasom
subunit
versu
activ
immunoproteasom
analogu
infect
ident
label
subunit
determin
base
reactiv
molecular
weight
determin
ingel
fluoresc
imag
demonstr
activ
proteasom
subunit
remain
rel
unchang
activ
immunoproteasom
subunit
increas
significantli
earli
stage
infect
decreas
infect
progress
keller
et
al
probe
previous
demonstr
specif
proteasom
probe
verdo
et
al
li
et
al
keller
et
al
first
demonstr
use
specif
assess
regulatori
chang
activ
immunoproteasom
context
viral
infect
keller
et
al
increas
proteasom
activ
repres
part
host
respons
viral
infect
wherein
proteasom
degrad
protein
increas
order
gener
antigen
peptid
recruit
adapt
immun
respons
viral
target
proteasom
activ
could
therefor
potenti
immun
evas
strategi
recent
nasheri
et
al
use
activitybas
probe
orlistatalkyn
label
activ
proteasom
subunit
therebi
interrog
proteasom
activ
hepat
c
viru
infect
nasheri
et
al
shown
activ
multipl
member
proteasom
system
display
decreas
activ
hcv
infect
cell
display
broad
specif
chymotrypsinlik
hydrolas
activ
marqu
et
al
atpas
regul
proteasom
activ
coux
et
al
two
immunoproteasom
subunit
de
graaf
et
al
downregul
nasheri
et
al
interestingli
chang
protein
express
match
observ
chang
enzymat
activ
nasheri
et
al
altogeth
suggest
hcv
target
proteasom
degrad
alter
protein
express
posttransl
regul
part
effort
evad
immun
respons
furthermor
studi
highlight
advantag
activitybas
protein
profil
addit
tradit
proteom
studi
viral
induc
perturb
host
cell
system
nuclear
factor
kappa
b
transcript
factor
activ
viral
infect
induc
express
gene
involv
innat
immun
respons
oeckinghau
ghosh
signal
cascad
respons
activ
infect
reli
great
part
ubiquitin
key
signal
transduc
wertz
dixit
autoubiquitin
ubiquitin
ligas
promot
activ
kinas
wertz
dixit
kinas
ikk
complex
activ
via
phosphoryl
ubiquitin
wertz
dixit
van
gent
et
al
ikk
phosphoryl
result
ubiquitin
subsequ
degrad
oeckinghau
ghosh
sequest
cytoplasm
upon
degrad
transloc
nucleu
induc
express
antivir
proinflammatori
proapoptot
gene
oeckinghau
ghosh
activ
enzym
respons
regul
ubiquitin
therefor
interest
investig
interact
due
import
ubiquitin
immun
respons
infect
deubiquitin
enzym
dub
enzym
respons
remov
ubiquitin
ubiquitin
protein
cystein
proteas
excel
candid
suicidebas
activ
probe
borodovski
et
al
haub
probe
base
modifi
ubiquitin
protein
mimic
natur
substrat
dub
allow
specif
target
dub
ubiquitin
recombinantli
express
haemagglutinin
tag
ha
function
report
enzym
label
thiolreact
group
function
warhead
subsequ
ad
cterminu
via
inteinbas
chemic
ligat
sever
variant
produc
contain
sever
differ
warhead
chloroethylamin
cl
bromoethylamin
bromopropylamin
glycin
vinylmethylsulfon
vs
glycin
vinyl
methylest
vme
glycin
vinyl
phenylsulfon
vsph
glycin
vinylcyanid
vcn
borodovski
et
al
immunoblot
msm
profil
label
dub
demonstr
slight
signific
differ
label
pattern
haub
probe
borodovski
et
al
ovaa
et
al
probe
contain
vinyl
methylest
warhead
haubvm
fig
display
broadest
label
capac
use
subsequ
studi
borodovski
et
al
ovaa
et
al
develop
probe
ovaa
et
al
appli
interrog
activ
host
cell
deubiquitin
protein
infect
herpesviru
viru
ebv
ovaa
et
al
herpesvirus
larg
doublestrand
dna
virus
shown
modul
immun
respons
via
multipl
differ
mechan
use
haubvm
probe
ovaa
et
al
label
activ
host
cell
deubiquitin
enzym
identifi
multipl
dub
whose
activ
increas
infect
sever
enzym
shown
regul
pathway
neg
regul
activ
deubiquitin
harhaj
dixit
decreas
nfkb
signal
deubiquitin
ikk
nanduri
et
al
contrari
shown
requir
degrad
therefor
nfkb
activ
mazumdar
et
al
altogeth
ovaa
et
al
demonstr
herpesviru
ebv
differenti
regul
dub
implic
regul
innat
immun
respons
suggest
may
provir
immun
evas
mechan
kattenhorn
et
al
appli
haubvm
probe
design
borodovski
et
al
studi
perturb
ubiquitinationregul
enzym
infect
herp
simplex
viru
herpesviru
relat
ebv
msm
analysi
label
protein
identifi
enzym
correspond
known
dub
whose
sequenc
found
correspond
viral
protein
unknown
function
larg
tegument
protein
deneddylas
kattenhorn
et
al
perturb
host
cell
process
virus
usual
indirect
limit
size
viral
genom
mean
viru
encod
function
requir
herpesvirus
howev
larg
doublestrand
dna
virus
possess
larger
complex
genom
simpler
rna
virus
discuss
elsewher
chapter
exampl
encod
approxim
protein
macdonald
et
al
share
signific
sequenc
homolog
dub
known
time
kattenhorn
et
al
tradit
bioinformat
could
therefor
predict
function
discoveri
highlight
one
uniqu
advantag
activitybas
protein
profil
report
directli
function
output
enzym
allow
identif
novel
target
recent
shown
deubiquitin
prevent
degrad
promot
sequestr
outsid
nucleu
therebi
interf
activ
innat
immun
respons
ye
et
al
follow
discoveri
sever
research
group
postul
exist
homolog
deubiquitin
enzym
close
relat
virus
whose
function
remain
undiscov
due
lack
homolog
previous
characteris
dub
establish
effect
probe
herpesviru
deubiquitin
enzym
haubvm
use
interrog
activ
viral
protein
sever
differ
virus
schlieker
et
al
identifi
viru
protein
murin
cytomegaloviru
protein
mcmv
possess
signific
sequenc
homolog
schlieker
et
al
subsequ
demonstr
label
haubvm
probe
indic
protein
enzym
target
hydrolys
ubiquitin
protein
schlieker
et
al
later
shown
act
similarli
inhibit
activ
catalys
remov
ubiquitin
sequest
protein
van
gent
et
al
furthermor
demonstr
exert
addit
control
pathway
deubiquitin
subunit
ikk
therebi
inhibit
propag
tlr
signal
result
activ
saito
et
al
van
gent
et
al
taken
togeth
demonstr
ebv
use
viral
encod
dub
function
inhibit
activ
antivir
innat
immun
respons
anoth
herpesviru
human
cytomegaloviru
hcmv
also
shown
encod
deubiquitin
enzym
wang
et
al
haubvm
label
high
molecular
weight
enzym
whose
role
infect
previous
unknown
absenc
deubiquitin
activ
virion
product
significantli
inhibit
though
entir
block
indic
deubiquitin
activ
contribut
requir
virion
product
haubvm
also
use
identifi
similar
deubiquitin
protein
murin
gamma
herpesviru
marek
diseas
viru
mdv
gredmark
et
al
jarosinski
et
al
assign
novel
function
one
wellknown
use
abpp
essenti
primari
step
characteris
poorli
understood
enzym
open
avenu
investig
contextualis
reactiv
enzym
enabl
determin
specif
target
ubiquitin
chain
target
dub
discuss
section
link
one
seven
differ
linkag
subtyp
correspond
locat
lysin
residu
next
ubiquitin
bound
new
diubvm
probe
develop
contain
two
ubiquitin
moieti
conjug
one
seven
possibl
linkag
type
therebi
allow
determin
dub
linkag
specif
mulder
et
al
probe
use
interrog
substrat
specif
sar
coronaviru
papainlik
proteas
plpro
deubiquitin
enzym
thought
play
role
innat
immun
evas
et
al
structur
basi
plpro
specif
determin
cocrystalis
conjunct
diubvm
probe
cocrystalis
enzym
substrat
often
challeng
enzym
catalys
substrat
releas
product
use
substratemimet
abp
ensur
retain
within
activ
site
preserv
interact
give
rise
specif
well
activ
conform
enzym
show
plpro
interact
two
ubiquitin
moieti
interact
interfac
two
et
al
suggest
specif
origin
orient
ubiquitin
protein
pocket
recognit
linkag
screen
panel
ubvm
probe
contain
monoub
diub
possess
differ
linkag
type
demonstr
plpro
possess
similarli
low
label
effici
monoub
diub
probe
et
al
lend
support
idea
interact
properli
orient
ubiquitin
stabilis
enzymesubstr
complex
contribut
specif
sar
plpro
last
stage
viral
life
cycl
consist
assembl
viral
particl
releas
extracellular
space
major
contribut
made
abpp
toward
understand
viru
infect
focus
viral
entri
replic
case
due
limit
cell
cultur
model
infect
model
could
replic
genom
unabl
effici
assembl
infecti
particl
lohmann
bartenschlag
viral
assembl
egress
reli
host
factor
transloc
plasma
membran
exit
cell
profil
enzymat
activ
process
signific
interest
hijack
cellular
traffick
play
signific
role
packag
secret
virus
copi
system
essenti
correct
localis
iav
particl
hcv
utilis
copii
system
travel
er
golgi
point
traffick
vldl
secretori
pathway
pohl
et
al
sy
et
al
system
regul
part
rab
gtpase
host
cell
enzym
play
import
role
traffick
throughout
cell
hutagalung
novick
implic
egress
multipl
virus
hogu
et
al
pohl
et
al
takac
et
al
shown
essenti
traffick
iav
rna
perinuclear
region
plasma
membran
pohl
et
al
anoth
rab
protein
propos
mediat
transport
nascent
hcv
virion
er
golgi
takac
et
al
rab
protein
also
shown
play
role
dna
viru
egress
case
herpesvirus
hogu
et
al
altogeth
suggest
rab
gtpase
activ
could
interest
target
activitybas
profil
viral
infect
iav
bud
shown
involv
activ
class
atpas
mitochondri
enzym
localis
plasma
membran
necessari
effici
bud
new
virion
though
precis
natur
contribut
yet
fulli
understood
pohl
et
al
atpbas
probe
previous
use
profil
host
enzym
activ
dengu
infect
vetter
et
al
appli
profil
chang
activ
variou
atpas
iav
infect
could
yield
new
inform
regard
enzym
recruit
utilis
viral
egress
lipid
regulatori
system
play
import
role
earlier
stage
viral
life
cycl
continu
play
import
role
viral
egress
hcv
provid
good
exampl
egress
reli
verylowdensitylipoparticl
vldl
secretori
pathway
releas
matur
viru
particl
bloodstream
neufeldt
et
al
certain
vldlassoci
enzym
triglyceriderecruit
enzym
phospholipid
synthesi
enzym
identifi
pro
antivir
hcv
host
factor
howev
interact
enzym
hcv
fulli
understood
vieyr
et
al
beilstein
et
al
profil
enzym
regul
pathway
could
therefor
reveal
novel
inform
clarifi
hijack
hcv
even
virus
influenza
reli
lipid
secretori
pathway
still
alter
cell
lipid
profil
order
exit
bloodstream
pohl
et
al
influenza
viru
egress
occur
bud
plasma
membran
process
requir
alter
membran
lipid
composit
pohl
et
al
profil
chang
lipid
regulatori
network
assembl
egress
virion
could
therefor
yield
new
inform
improv
understand
interact
late
stage
infect
gener
activitybas
profil
later
stage
viral
infect
potenti
yield
novel
host
factor
requir
product
infect
target
secret
new
virion
could
play
import
role
within
combinatori
antivir
strategi
limit
spread
viral
infect
select
label
viral
enzym
enabl
measur
activ
within
complex
proteom
viral
enzym
label
broadli
reactiv
probe
fluorophosphon
haubvm
discuss
preced
section
difficult
detect
amongst
numer
host
cell
enzym
label
simultan
blai
et
al
reason
specif
select
probe
develop
multipl
viral
enzym
infecti
particl
influenza
viru
iav
common
caus
flu
incorpor
two
viral
enzym
surfac
haemagglutinin
ha
neuraminidas
na
wohlbold
krammer
na
known
play
mani
role
wellestablish
sialidas
activ
cleav
sialic
acid
nascent
virion
follow
virion
secret
wohlbold
krammer
na
enzymat
activ
also
suggest
play
role
viral
entri
though
mechan
could
occur
well
establish
su
et
al
wohlbold
krammer
na
activ
site
highli
conserv
strain
iav
strain
make
na
attract
target
chemic
probe
well
therapeut
drug
wohlbold
krammer
lu
et
al
report
synthesi
mechanismbas
neuraminidas
probe
consist
sialic
acid
target
moieti
orthodifluoromethyl
phenyl
warhead
attach
biotin
report
tag
lu
et
al
demonstr
probe
abl
specif
label
neuraminidas
could
use
detect
neuraminidas
activ
particular
interest
studi
demonstr
uncommon
applic
activitybas
probe
isol
viral
particl
immobilis
probe
bound
na
enzym
present
particl
surfac
therebi
enabl
isol
entir
virion
lu
et
al
probe
abl
coval
label
iav
na
sever
limit
larg
size
multipl
ring
necessit
millimolar
concentr
label
even
purifi
protein
probe
also
unabl
penetr
cell
membran
preclud
applic
probe
complex
system
lastli
though
sialic
acid
convey
select
difluoromethyl
phenyl
warhead
nevertheless
react
nonspecif
multipl
target
complex
environ
tsai
et
al
streamlin
probe
report
tsai
et
al
instead
inclus
separ
warhead
group
addit
sialic
acid
moieti
sialic
acid
sugar
modifi
includ
fluorin
displac
hydroxyl
group
hydrogen
respect
electronwithdraw
properti
fluorin
transform
probe
irrevers
mechanismbas
inhibitor
two
probe
made
dfsa
esterprotect
probe
pdfsa
contain
sialic
acid
warhead
alkyn
handl
fig
tsai
et
al
pdfsa
abl
label
na
situ
micromolar
concentr
allow
imag
subcellular
localis
viral
enzym
infect
tsai
et
al
pdfsa
abl
label
wildtyp
na
well
mutant
na
resist
activesit
antivir
indic
probe
could
appli
screen
presenc
drugresist
strain
competit
abpp
tsai
et
al
zika
viru
recent
subject
intern
attent
follow
south
american
outbreak
caus
dramat
increas
rate
microencephali
newborn
infant
lei
et
al
zika
viru
like
positivestrand
rna
virus
encod
serin
proteas
cleav
precursor
polyprotein
matur
viral
protein
activ
proteas
essenti
establish
product
infect
develop
tool
capabl
characteris
activ
regul
great
interest
proteas
capabl
display
high
select
specif
amino
acid
sequenc
cleav
possibl
design
activitybas
probe
base
sequenc
probe
risk
lack
specif
individu
proteas
due
overlap
substrat
specif
close
relat
enzym
recent
problem
address
use
unnatur
amino
acid
expand
chemic
space
peptid
build
block
hybrid
combinatori
substrat
librari
hycosul
use
unnatur
amino
acid
addit
twenti
canon
one
build
optim
substrat
contain
variabl
acid
sequenc
target
pocket
proteas
activ
site
kasperkiewicz
et
al
allow
specif
activitybas
label
fluorogen
coumarin
diphenyl
phosphat
warhead
ad
kasperkiewicz
et
al
librari
previous
use
design
probe
target
human
proteas
kasperkiewicz
et
al
poreba
et
al
recent
hycosul
methodolog
appli
design
probe
rapidli
label
zika
proteas
low
nanomolar
concentr
fig
rut
et
al
probe
potenti
appli
interrog
activ
zika
infect
studi
demonstr
use
applic
unnatur
amino
acid
potenti
use
design
activitybas
probe
viral
proteas
major
activitybas
profil
report
chapter
perform
either
vitro
proteom
isol
anim
model
cultur
cell
situ
live
cell
monocultur
abl
provid
inform
target
viral
mediat
host
cell
system
physiolog
relev
inform
subject
doubt
cell
lysi
protein
isol
procedur
use
vitro
label
potenti
destroy
enzymecofactor
interact
may
result
loss
inform
enzym
true
activ
vivo
label
cell
situ
preserv
regul
catalyt
activ
present
live
cell
howev
alway
accur
repres
effect
infect
live
organ
develop
probe
could
administ
vivo
would
provid
opportun
characteris
chang
enzym
activ
complex
physiolog
relev
manner
past
decad
activitybas
protein
profil
proven
use
chemic
proteom
tool
interrog
role
enzym
play
viral
infect
provid
inform
otherwis
access
tradit
genom
proteom
method
abpp
use
quantifi
enzymat
activ
detect
chang
localis
activ
enzym
identifi
interact
regul
activ
assign
novel
function
protein
play
import
role
viral
infect
consid
part
larger
bodi
research
greatli
contribut
understand
viral
infect
host
respons
